New Roche drug helps melanoma patients | March 16, 2012 | Pleasanton Weekly | |

Pleasanton Weekly

- March 16, 2012

New Roche drug helps melanoma patients

Twice-a-day pill shown to improve patient survival

A metastatic melanoma drug developed by Roche Molecular Diagnostics of Pleasanton in concert with Berkeley-based Plexxikon Inc. has been approved by European regulators for adult patients with the most aggressive form of skin cancer.

This story contains 169 words.

Stories older than 90 days are available only to subscribing members. Please help sustain quality local journalism by becoming a subscribing member today.

If you are already a subscriber, please log in so you can continue to enjoy unlimited access to stories and archives. Subscriptions start at $5 per month and may be cancelled at any time.

Log in     Subscribe